PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Fexofenadine hydrochloride - Allergic rhinitis
PAD Profile : Fexofenadine hydrochloride - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Telfast
Traffic Light Status
Status 1 of 1.
Status :
Green (see narrative)
Important
Formulations :
- Tablets
Important Information :
2nd line to loratadine / cetirizine tablets. 120mg tablets available to buy over the counter.180mg tablets NOT licensed for allergic rhinitis. 30mg reserved for paediatrics.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Fluticasone furoate
- Cetirizine hydrochloride
- Loratadine
- Triamcinolone acetonide
- Beclometasone dipropionate
- Azelastine hydrochloride
- Desloratadine
- Levocetirizine
- Budesonide
- Mometasone furoate
- Ipratropium bromide
- Bilastine
- Mizolastine
- Acrivastine
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Mometasone furoate/olopatadine hydrochloride
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
- Fluticasone propionate (Nasal)
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Fexofenadine is recommended as a 2nd line treatment option.
Prescribe generically
NOTE - the 180mg tablets are NOT licensed for allergic rhinitis
Associated BNF Codes
03. Respiratory System
03.04.01. Antihistamines